Tumor-derived EVs containing miR-424 inhibit the expression levels of costimulatory molecule CD80 expressed on DCs and the expression of CD28 on Th cells and Tc cells, impairing T cell activation and proliferation [98]. Here, CD80 is linked to neoplasm.